| 2025 | Manski-Nankervis, J. -A., Hunter, B., Lumsden, N., Laughlin, A., McMorrow, R., Boyle, D., . . . Nelson, C. (2025). Effectiveness of Electronic Quality Improvement Activities to Reduce Cardiovascular Disease Risk in People With Chronic Kidney Disease in General Practice: Cluster Randomized Trial With Active Control.. JMIR formative research, 9, e54147. DOI |
| 2025 | Logan, B., Pascoe, E. M., Viecelli, A. K., Johnson, D. W., Comans, T., Hawley, C. M., . . . Hubbard, R. E. (2025). Baseline Characteristics of Frailty and Disease Stage in Older People Living With CKD. Kidney International Reports, 10(1), 120-133. DOI |
| 2025 | Alexiuk, J., Harasemiw, O., Vanderlinden, J., Verrelli, D., Tarca, B., Collister, D., . . . Bohm, C. (2025). Identifying Research Priorities for Cognition in CKD: A Delphi Study.. Kidney360. DOI |
| 2025 | Jesudason, S., & Lightstone, L. (2025). Pregnancy as a Window to Current and Future Kidney Health–An Opportunity. K • Clinical Outcomes of Proximal Tibia Shaft Fractures Managed with Intramedullary Interlocking Nailing Using Expert Tibia Nailing Rajesh K. Ambulgekar, Pradeep Abarao Sangnod
Abstract Background:Tibial shaft fractures are common orthopedic injuries, often resulting from high-energy trauma in younger individuals and falls in older adults. These fractures present a clinical challenge due to their complex nature and associated complications. Intramedullary nailing, particularly with the Expert Tibial Nail (ETN), has emerged as a preferred surgical technique for effective management. Methods:A prospective observational study was conducted over 18 months at a tertiary care hospital to assess the clinical outcomes of proximal tibia shaft fractures treated with intramedullary interlocking nailing using the ETN system. A total of 30 patients aged 18-75 were included, with follow-ups conducted at intervals up to six months post-surgery. Outcomes were evaluated using rad • . Author manuscript; available in PMC: 2021 Feb 1. Published in sista edited struktur as: Am J Kidney Dis. 2019 Nov 5;75(2):225–234. doi: 10.1053/j.ajkd.2019.07.016 AbstractRationale & Objective:Metabolic acidosis associated with chronic kidney disease (CKD) may contribute to muscle dysfunction and bone disease. We aimed to test whether treatment with sodium bicarbonate improves muscle and bone outcomes. Study Design:Multi-center, randomized, placebo-controlled clinical trial. Setting & Participants:149 patients with CKD stages 3 and 4 between 7/2011 and 4/2016 at three centers in Cleveland, OH and the stadsdel i new york, NY. Intervention:Sodium bicarbonate (NaBicarb) (0.4 mEq per kilogram of ideal body weight per day) (n=74) or identical placebo (n=75). Outcomes:The dual primary outcomes were muscle function assessed bygd sit-to-stand test and bone mineral density. Muscle biopsies were collected at baseline and 2 months. Participants were seen at baseline, 2, 6, 12 and 24
|